CN Patent
CN111615390A — 光稳定性及溶出性优异的药物制剂
Assigned to Shionogi and Co Ltd · Expires 2020-09-01 · 6y expired
What this patent protects
本发明提供一种制剂,其为:在含有式(I)表示的化合物、其盐或其结晶的制剂中以光稳定化物质及聚合物进行包覆,尤其是以氧化钛、滑石中的1种以上作为光稳定化物质,以羟丙基甲基纤维素作为聚合物进行包覆,由此即使经光照射也几乎不着色。
USPTO Abstract
本发明提供一种制剂,其为:在含有式(I)表示的化合物、其盐或其结晶的制剂中以光稳定化物质及聚合物进行包覆,尤其是以氧化钛、滑石中的1种以上作为光稳定化物质,以羟丙基甲基纤维素作为聚合物进行包覆,由此即使经光照射也几乎不着色。
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.